FDA’s History with Lab Developed Tests Public Meeting on Oversight of Laboratory Developed Tests July 19 – 20, 2010 Courtney C. Harper, Ph.D. Office of.
2008 Health Care Forecast Conference Prospects for Federal Health Legislation Irvine, California February 21, 2008 Dean A. Rosen Mehlman Vogel Castagnetti,
Medical Device Reimbursement in Japan Presented to MassMEDIC April 10, 2008 Paul Barry Director, International Trade & Health Policy Boston Scientific.
Do we want a Genetically Modified future? Greg Revell [email protected] Gene Ethics Network.
Fulfilling the Promise of Medicine Together Preparing for an IDE Application John McLane, Ph.D. COO & Vice President Clinical and Regulatory Affairs Clinquest,
508 Paving Way for Personalized Medicine 2013_reduced
What is ACCPAC? ACCPAC is ACC’s political action committee ACCPAC opens the door and assures a seat at the table with key members of Congress 100% of personal.
FDA’s History with Lab Developed Tests
Beltway Roundup Changes at FDA Capitol Hill Action
Medical Device Development Tools: FDA CDRH Pilot Program
PDF.js Viewer
Update of CDC/WHO Guidance on Quality Assurance for HIV-Related Point-Of-Care Testing
